News/SEC filing/Oct 30, 2025, 11:15 AM ET

Eli Lilly files quarterly report (10-Q) for the period ended Sep 30, 2025

Eli LillyLLY

Eli Lilly filed its quarterly report on Form 10-Q with the SEC on Oct 30, 2025, 11:15 AM ET, covering the quarter ended Sep 30, 2025. It reports fiscal Q3 2025 results.

  • Revenue: $17.60B (+53.9% from $11.44B a year earlier)
  • Net income: $5.58B (+475.3% from $970.3M a year earlier)
  • Diluted EPS: $6.21 (+480.4% from $1.07 a year earlier)
  • Form 10-Q accepted by EDGAR Oct 30, 2025, 11:15 AM ET
  • Accession number 0000059478-25-000254
Source
SEC EDGAR
Oct 30, 2025, 11:15 AM ET
Read the original ↗

SEC filing 10-Q · accession 0000059478-25-000254 · sec.gov ↗